Veterinary medicine sales continue to grow in Russia

By the end of January–November 2024, the retail market for veterinary medicine in Russia, including online sales, reached €376.9 mln, which represents a 15.2% increase compared to the same period in 2023. A total of 230 million minimum dosage units were sold during the 11 months, an 8.4% rise from the previous year.

Online sales drive growth
The primary contributor to the market growth was online sales, which surged by 57.5% in monetary terms and 36.7% in minimum dosage units. In comparison, offline sales grew by only 7.4% in ruble terms and 4% in minimum dosage units. This significant growth in online sales is attributed to an expanded product range, including medicine imported through gray import due to official supply suspension. Moreover, online shopping convenience and more competitive pricing are driving consumers away from offline channels.

This trend is especially pronounced in Moscow, the Moscow region, and Saint Petersburg, where online services are traditionally well-developed. In these areas, a decline in veterinary medicine offline sales was recorded in physical terms, with the steepest drop in Moscow (-5% in minimum dosage units). Although monetary sales in these regions remain positive, their growth rates are significantly below the industry average and inflation levels.

Regional highlights
The highest growth in physical sales volumes for January–November 2024 was recorded in Stavropol territory (+25%), Rostov region (+11%), and Novosibirsk region (+11%). Ruble-based growth rates in these regions were nearly identical, ranging from 12% to 13%. However, the consumption structure in each region exhibits distinct characteristics.

In Novosibirsk region, Bravecto (MSD) remains the leader in monetary sale terms, despite the official supply absence and declining sales volumes. The strongest growth was demonstrated by Sinuxol (up 3.9 times) from NITA-FARM and Fiprist (up 3.3 times) from KRKA.

In Stavropol territory, products from the Bars line by Agrovetzashchita lead the market in monetary terms, with Azitronit from NITA-FARM showing the most significant sales growth.

In Rostov region, products under the Inspector brand by Ecoprom hold the top position, while Cladaxa from KRKA demonstrated the fastest growth in sales.

Market reorganization and domestic brands
According to RNC Pharma analysts, several foreign manufacturers withdrawal has triggered active market reorganization in the regions. Russian companies are strengthening their positions by offering both replacements and new products. Brands focusing on local needs and swiftly adapting to new conditions are achieving the greatest success.